Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Naina R. Verghese"'
Publikováno v:
Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Background and objectives: Governments in Asia Pacific (APAC) are increasingly using pharmaceutical pricing strategies to contain rising healthcare costs. The objective of this narrative review is to discuss formal pricing strategies for reimbursed p
Externí odkaz:
https://doaj.org/article/f98da6f7c4f247f49beae75e7c61c123
Autor:
Eric A. Finkelstein, Chetna Malhotra, Naina R. Verghese, Sanjeeva Kumari, Gayatri Palat, Priya Chandran, Jean Jacob, Irene Teo, Semra Ozdemir, Vineela Rapelli
Publikováno v:
BMC Palliative Care, Vol 18, Iss 1, Pp 1-12 (2019)
Background Patients with advanced cancer often experience poor health-related quality-of-life (HRQoL) due to cancer and treatment-related side-effects. With India’s palliative care landscape in its infancy, there is a concern that advanced cancer p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58ec01121a89cf10e8f91329ffafbaab
http://link.springer.com/article/10.1186/s12904-019-0465-y
http://link.springer.com/article/10.1186/s12904-019-0465-y
Autor:
Eric A. Finkelstein, Drishti Baid, Amanda Yr. Lam, Su-Yen Goh, Adoree Yy. Lim, Ling Zhu, Naina R. Verghese, Semra Ozdemir, Phong Ching Lee, Sonali Ganguly
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 23(7)
Objectives To quantify patients’ maximum acceptable risk (MAR) of urinary and genital tract infections (UGTI) in exchange for benefits associated with treatments for managing type 2 diabetes mellitus (T2DM). Methods In a discrete choice experiment,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4465b7238c2c511f977b2f5455887a5
https://pubmed.ncbi.nlm.nih.gov/32762985
https://pubmed.ncbi.nlm.nih.gov/32762985
Autor:
Naina R. Verghese, Eric A. Finkelstein
Publikováno v:
Clinical Obesity. 9:e12294
Recent medical advancements have led to new modes of treatment for non-surgical weight loss, including several new medications. Our aim was to conduct an incremental cost-effectiveness analysis for all commercially available, evidence-based non-surgi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563c456341666658bf5c3e66e44b3c0e
https://doi.org/10.1111/cob.12294
https://doi.org/10.1111/cob.12294
Publikováno v:
Journal of Market Access & Health Policy
Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Background and objectives: Governments in Asia Pacific (APAC) are increasingly using pharmaceutical pricing strategies to contain rising healthcare costs. The objective of this narrative review is to discuss formal pricing strategies for reimbursed p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f5d1641eb407f0e370c1b501702b43
https://doi.org/10.1080/20016689.2019.1601060
https://doi.org/10.1080/20016689.2019.1601060
Autor:
Verghese, Naina R.1 (AUTHOR), Barrenetxea, Jon1 (AUTHOR), Bhargava, Yukti2 (AUTHOR), Agrawal, Sagun1 (AUTHOR), Finkelstein, Eric Andrew1,3 (AUTHOR) eric.finkelstein@duke-nus.edu.sg
Publikováno v:
Journal of Market Access & Health Policy. Dec2019, Vol. 7 Issue 1, p1-4. 4p.
Autor:
Finkelstein, Eric A.1,2 (AUTHOR) eric.finkelstein@duke-nus.edu.sg, Verghese, Naina R.1 (AUTHOR)
Publikováno v:
Clinical Obesity. Apr2019, Vol. 9 Issue 2, pN.PAG-N.PAG. 1p.